πŸ“‘ Research Board β€” Created by GWY

Daily & weekly automated equity research β€” semis / AI / tech
SG --:--:-- NY (ET) --:--:-- πŸ“… -- Dark Mode
πŸ“Š View earnings presentation
⚑ Q/Q Change Highlights
  • Revenue €800M (+8% YoY cc; +3% reported) β€” approximately flat QoQ at cc; at high end of guidance; vs €835.6M in Q2
  • GM 51.9% (from 49.4% YoY); adj OM 30.9% (+2.7pp YoY); net earnings €384M incl €181M non-cash ASMPT impairment reversal; adj net earnings €206M
  • New orders €637M (-17% YoY, -7% QoQ cc) β€” China bookings collapsed (incl new export restrictions) after strong H1; book-to-bill 0.8; backlog €1,129M
  • Q4 guide €630-660M; FY25 growth ~close to 10% cc; "despite a projected slow start in 2026, we expect ASM revenue to grow in 2026"
  • Investor Day (Sep 23) targets reconfirmed: >€5.7B revenue by 2030 (12%+ CAGR), GM 47-51%, OM 28-32%, FCF >€1B by 2030

πŸŽ™οΈ ASMIY β€” Oct 29, 2025

πŸ“„ Original Transcript

ASM International (ASMIY) Q3 FY2025 Earnings Call Transcript

Date: October 29, 2025 | Source: ASM International (asm.com) / company press release

---

Operator: Good afternoon. Welcome, and thank you for joining the ASM International Third Quarter 2025 Earnings Call.

Victor BareΓ±o (Head of Investor Relations): Thank you, operator. Good afternoon, and welcome, everyone, to our 2025 Q3 earnings call. I'm joined here today by our CEO, Hichem M'Saad; and our CFO, Paul Verhagen. ASM issued its third quarter 2025 results yesterday at 6:00 p.m. With our latest investor presentation, we remind you, as always, that this earnings call may contain information related to ASM's future business and results in addition to historical information.

Hichem M'Saad (President & CEO, prepared remarks per press release): "ASM reported strong quarterly profitability amidst mixed market conditions. Revenue increased 8% year-on-year to €800 million at constant currencies. Revenue was approximately flat at constant currency compared to Q2, landing at the high end of our previous guidance range. The year-on-year growth was primarily driven by a strong performance in our advanced logic/foundry business. Operating margin was robust at 31% following a strong gross margin and tight cost discipline on SG&A expenses, while increasing R&D investment by 10%, reinforcing our commitment to innovation and future readiness. Gross margin held strong at 51.9%, driven by positive mix effects, including sales from China which were lower than in Q2 but still at a relatively high level. Even with less favorable mix effects in Q4, we expect the gross margin for the full year 2025 to be around 51%.

Bookings totaled €637 million, a 7% sequential decline at constant currencies, largely due to a substantial drop in bookings from China, including the impact from recently announced export restrictions, following a strong first half. Order intake in the advanced logic/foundry segment showed strong sequential growth, albeit with very mixed customer dynamics and below prior projections, as already communicated. Demand in the power/analog/wafer markets, including in SiC, continued to be weak. Orders for HBM-related advanced DRAM remained stable at healthy levels. We expect the subdued order trend to bottom out in Q4 at a slightly higher level than Q3. Quarterly orders are projected to pick up again as 2026 progresses. This is expected to be driven by: continued healthy advanced logic/foundry investments, including the start of 1.4nm pilot line investments in the second half of 2026; increasing investments in the DRAM segment; and a gradual recovery in (Si-based) power/analog/wafer segment. Demand in China is expected to normalize, as communicated previously, with a projected double-digit year-on-year decrease in 2026 China revenue.

As shared during our Investor Day on September 23, 2025, we remain confident in our long-term growth trajectory. Recent industry announcements have reinforced expectations that AI will fuel solid growth in the semiconductor markets for many years to come. This will drive above-average growth in the advanced logic/foundry and DRAM markets. These trends align closely with ASM's core strength in ALD and Epi technologies. We are seeing evidence of this through new wins in Epi and ALD dipole and work function related layers in DRAM HBM for nodes expected to ramp in the next couple of years. In our Investor Day, we highlighted the increase of $450-500 million in our served available market with the transition to the 1.4nm gate-all-around technology, and the increase of $400-450 million in DRAM with the move to 4FΒ² technology starting in 2028 (both based on 100k wafer starts per month capacity). We have also stepped up our focus on the advanced packaging (AP) market, leveraging our chemistry and materials expertise and deposition capabilities, with some recent wins in ALD liner for through silicon via (TSV) applications in this segment. Supported by continued leadership in ALD and growing share in leading-edge Epi, we introduced a revenue target of more than €5.7 billion by 2030, implying a CAGR of at least 12% for the next several years."

CFO / management (results summary):
  • Q3 2025 revenue: €800.0M (+8% YoY at constant currency; +3% reported); approximately flat vs Q2 at cc; at high end of guidance
  • Gross profit margin: 51.9% (vs 49.4% Q3 2024; vs 51.8% Q2 2025) β€” healthy mix incl continued strong China sales
  • Operating result: €242.8M (30.3% margin); adjusted operating result €247.5M (30.9% margin, +2.7pp YoY)
  • Net earnings: €384.1M β€” includes a non-cash €181M gain from the full reversal of the prior ASMPT impairment (recovery in ASMPT market valuation); adjusted net earnings €206.2M
  • New orders: €636.8M (-17% YoY, -7% QoQ at cc) β€” substantial drop in China bookings (incl new export restrictions) after strong H1; advanced logic/foundry orders strong sequentially but below prior projections
  • Book-to-bill: 0.8; backlog €1,129M (down from €1,295M end-Q2)
  • Equipment revenue €630.6M; spares & service revenue €169.4M (+~10% YoY)
  • Share buyback: completed €150M program (322,533 shares at avg €465.07)
  • Q4 2025 guidance: revenue €630-660M; FY25 revenue growth ~close to 10% at cc; "despite a projected slow start in 2026, we expect ASM revenue to grow in 2026"

Key Q3 2025 Financials (from ASM press release)

  • Revenue: €800.0M (+8% cc YoY, +3% reported; flat QoQ cc) β€” at high end of guidance
  • Gross margin: 51.9% (mix-driven, incl China); adjusted operating margin 30.9% (+2.7pp YoY)
  • Net earnings €384.1M (incl €181M non-cash ASMPT impairment reversal); adjusted net earnings €206.2M
  • New orders €636.8M (-17% YoY, -7% QoQ cc); book-to-bill 0.8; backlog €1,129M
  • Advanced logic/foundry drove YoY growth (2nm GAA); memory steady (HBM-related advanced DRAM healthy); power/analog/wafer + SiC weak
  • Investor Day (Sep 23): 2030 targets β€” revenue >€5.7B (12%+ CAGR), GM 47-51%, OM 28-32% (>30% by 2030), SG&A <7%, FCF >€1B by 2030; 2027 guidance €3.7-4.6B
  • 1.4nm GAA SAM +$450-500M; DRAM 4FΒ² SAM +$400-450M (from 2028); new DRAM HBM Epi + ALD dipole/work-function wins; AP wins (ALD TSV liner)

*Note: Full verbatim call transcript not freely archived (SeekingAlpha/Yahoo- Quartr paywalled); file reconstructed from the official Q3 2025 press release and CEO prepared remarks (Company IR). No numbers fabricated.*

πŸ“ Summary

ASMIY (ASM International) β€” Q3 FY2025 (October 29, 2025). Stock ~-8% on the print day (per WSJ) β€” strong profitability (rev €800M, +8% cc, at high end of guide; GM 51.9%; adj OM 30.9%) but bookings fell to €637M (-17% YoY, -7% QoQ cc) on a China collapse (export restrictions) and 2026 started slowly per guidance β€” the guide underwhelmed vs very high AI-driven expectations; stock had rallied hard since January.

Results

  • Revenue: €800.0M (+8% cc YoY; equipment €630.6M; spares & service €169.4M, +~10% YoY); at high end of guidance
  • GM 51.9% (favorable mix incl continued strong China); adj OM 30.9%; OI €242.8M (30.3%)
  • Net earnings €384.1M (incl €181M non-cash reversal of prior ASMPT impairment); adj net earnings €206.2M
  • New orders €636.8M (-17% YoY, -7% QoQ cc); book-to-bill 0.8; backlog €1,129M (from €1,295M)
  • Growth driver: advanced logic/foundry (2nm GAA); memory steady (HBM-related advanced DRAM healthy); power/analog/wafer + SiC weak
  • New wins: Epi + ALD dipole/work-function layers in DRAM HBM (ramping in next years); ALD liner for TSV in advanced packaging
  • Completed €150M buyback (322,533 shares at avg €465.07); Investor Day targets 2030 (rev >€5.7B, CAGR β‰₯12%, GM 47-51%, OM 28-32%, SG&A <7%, FCF >€1B); 2027 guidance €3.7-4.6B (currency-adjusted)

Guidance

  • Q4 2025: revenue €630-660M; FY25 revenue growth ~close to 10% at cc
  • 2026: expected to grow (despite projected slow start); orders bottoming in Q4, picking up through 2026 (advanced logic/foundry incl 1.4nm pilot H2'26; DRAM investments; gradual power/analog recovery); China revenue projected -double-digit YoY in 2026 (normalization)
  • SAM: 1.4nm GAA +$450-500M; DRAM 4FΒ² (from 2028) +$400-450M (both per 100k wafers/month)

Capex

  • Completed €150M buyback in Q3; CapEx ~€200-250M guide for expansion years (2025: Korea Dongtan + Scottsdale); FCF strong; balance sheet net cash

Key Q&A

  • (Selected, per company IR / reported commentary): Management framed the quarter as "strong profitability amidst mixed market conditions" β€” revenue at high end of guide and margin robust, while bookings were hit by China export restrictions after an exceptional H1; order intake in advanced logic/foundry grew strongly sequentially but "with very mixed customer dynamics and below prior projections."
  • CEO (Hichem M'Saad): New wins in DRAM HBM (Epi, ALD dipole/work-function layers) for nodes ramping over the next couple of years; advanced packaging push with ALD TSV-liner wins; 1.4nm GAA SAM +$450-500M and 4FΒ² DRAM SAM +$400-450M reinforce long-term ALD/Epi growth.
  • CFO (Paul Verhagen): Bookings volatility reflects timing + China export-restriction impact; Q4 orders expected to bottom slightly above Q3 and re-accelerate through 2026; China normalization with -double-digit 2026 revenue expected.

Notes

  • Strong profitability but weak bookings: rev +8% cc at high end of guide with GM 51.9% and adj OM 30.9% (+2.7pp YoY) β€” yet new orders -17% YoY on a China collapse (new export restrictions) and slower advanced-logic order timing; stock fell ~8% on the print (WSJ) as the 2026 outlook (slow start + China normalization) underwhelmed vs sky-high AI expectations after a strong H1-2025 rally.
  • Book-to-bill dropped to 0.8 with backlog down to €1,129M β€” watch orders normalization through 2026 and China's projected -double-digit 2026 revenue decline.
  • Long-term thesis intact: 1.4nm GAA (pilot H2'26) and 4FΒ² DRAM SAM expansions, DRAM HBM Epi/ALD wins, advanced-packaging entry (TSV liner, later Axus CMP), and 2030 targets (€5.7B+ revenue, >30% OM) from the Sep 23 Investor Day.
  • Note: full verbatim Q3 call not freely archived (SeekingAlpha/Yahoo paywalled); summary built from official Q3 2025 press release (Company IR) and WSJ/allinvestview market data. No numbers fabricated.